Article citationsMore>>

Zhou, Y., Zhou, A., Philip, A.M., Margolis, M., Babiker, F., Chang, P.Y., et al. (2023) Vision Outcomes of Long-Term Immunomodulatory and Steroid Therapy in Sympathetic Ophthalmia. American Journal of Ophthalmology, 253, 152-159.
https://doi.org/10.1016/j.ajo.2023.05.004

has been cited by the following article:

• TITLE: The Latest Research Progress on Sympathetic Ophthalmia—A Brief Literature Overview

  AUTHORS: Meinian Nong, Wenhao Ma

  KEYWORDS: Sympathetic Ophthalmia, Granulomatous Uveitis, Ocular Trauma, Panuveitis, Incidence

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.16 No.12, December 11, 2025

  ABSTRACT: Sympathetic ophthalmia (SO) is a rare bilateral granulomatous panuveitis, usually secondary to penetrating ocular trauma or intraocular surgery. Symptoms typically occur 5 days to 56 years after trauma or surgery, but most commonly manifest 2 weeks to 2 months postoperatively. The main clinical features include acute or chronic granulomatous uveitis, accompanied by Dalen-Fuchs nodules and choroiditis. Systemic glucocorticoids and steroid-sparing immunosuppressants remain the first-line treatments. This article systematically summarizes the latest research advances in the epidemiology, pathogenesis, and clinical management of SO, aiming to provide references for clinical practice and scientific research.